These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12082547)

  • 21. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM; Tsai WS; Ziauddin MF; Zuo J; Cole GW; Maxhimer JB; Fang B; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):883-91. PubMed ID: 15573073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
    Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
    Ehtesham M; Kabos P; Gutierrez MA; Chung NH; Griffith TS; Black KL; Yu JS
    Cancer Res; 2002 Dec; 62(24):7170-4. PubMed ID: 12499252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter.
    Katz MH; Spivack DE; Takimoto S; Fang B; Burton DW; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2003 Aug; 10(7):762-72. PubMed ID: 12900367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-liver cancer activity of TNF-related apoptosis-inducing ligand gene and its bystander effects.
    He C; Lao WF; Hu XT; Xu XM; Xu J; Fang BL
    World J Gastroenterol; 2004 Mar; 10(5):654-9. PubMed ID: 14991932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis.
    Griffith TS; Anderson RD; Davidson BL; Williams RD; Ratliff TL
    J Immunol; 2000 Sep; 165(5):2886-94. PubMed ID: 10946322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29.
    Xu XM; He C; Hu XT; Fang BL
    World J Gastroenterol; 2003 May; 9(5):965-9. PubMed ID: 12717839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
    Ren XW; Liang M; Meng X; Ye X; Ma H; Zhao Y; Guo J; Cai N; Chen HZ; Ye SL; Hu F
    Cancer Gene Ther; 2006 Feb; 13(2):159-68. PubMed ID: 16082383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts.
    Vanoosten RL; Moore JM; Ludwig AT; Griffith TS
    Mol Ther; 2005 Apr; 11(4):542-52. PubMed ID: 15771957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.
    Song K; Benhaga N; Anderson RL; Khosravi-Far R
    Cancer Res; 2006 Jun; 66(12):6304-11. PubMed ID: 16778207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC).
    Yang F; Shi P; Xi X; Yi S; Li H; Sun Q; Sun M
    Med Oncol; 2006; 23(2):191-204. PubMed ID: 16720919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
    Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus.
    Zhou W; Zhu H; Chen W; Hu X; Pang X; Zhang J; Huang X; Fang B; He C
    Cancer Gene Ther; 2011 May; 18(5):336-45. PubMed ID: 21183948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer.
    Kaliberov SA; Kaliberova LN; Stockard CR; Grizzle WE; Buchsbaum DJ
    Mol Ther; 2004 Dec; 10(6):1059-70. PubMed ID: 15564138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.